[1]
|
佟向军, 陈建国, 翟中和. 神经丝的结构与功能[J]. 细胞生物学杂志, 1998(2): 63-68.
|
[2]
|
Yuan, A. and Nixon, R.A. (2021) Neurofilament Proteins as Biomarkers to Monitor Neurological Diseases and the Efficacy of Therapies. Frontiers in Neuroscience, 15, 689938. https://doi.org/10.3389/fnins.2021.689938
|
[3]
|
张群, 林思睿, 吴琼英, 等. 神经丝轻链蛋白与神经系统疾病[J]. 中风与神经疾病杂志, 2019, 36(4): 380-382. https://doi.org/10.19845/j.cnki.zfysjjbzz.2019.04.026
|
[4]
|
Abu-Rumeileh, S., Abdelhak, A., Foschi, M., et al. (2023) The Multifaceted Role of Neurofilament Light Chain Protein in Non-Primary Neurological Diseases. Brain, 146, 421-437. https://doi.org/10.1093/brain/awac328
|
[5]
|
杨红旗, 陈生弟. 神经丝蛋白轻链在阿尔茨海默病诊断中的价值[J]. 阿尔茨海默病及相关病杂志, 2020, 3(3): 177-181 173.
|
[6]
|
Gentil, B.J., Tibshirani, M. and Durham, H.D. (2015) Neurofilament Dynamics and Involvement in Neurological Disorders. Cell and Tissue Research, 360, 609-620. https://doi.org/10.1007/s00441-014-2082-7
|
[7]
|
Malka-Gibor, E., Kornreich, M., Laser-Azogui, A., et al. (2017) Phosphorylation-Induced Mechanical Regulation of Intrinsically Disordered Neurofilament Proteins. Biophysical Journal, 112, 892-900. https://doi.org/10.1016/j.bpj.2016.12.050
|
[8]
|
Yuan, A., Sasaki, T., Kumar, A., et al. (2012) Peripherin Is a Subunit of Peripheral Nerve Neurofilaments: Implications for Differential Vulnerability of CNS and Peripheral Nervous System Axons. Journal of Neuroscience, 32, 8501-8508. https://doi.org/10.1523/JNEUROSCI.1081-12.2012
|
[9]
|
Deek, J., Chung, P.J., Kayser, J., et al. (2013) Neurofilament Sidearms Modulate Parallel and Crossed-Filament Orientations Inducing Nematic to Isotropic and Re-Entrant Birefringent Hydrogels. Nature Communications, 4, 2224. https://doi.org/10.1038/ncomms3224
|
[10]
|
Khalil, M., Teunissen, C.E., Otto, M., et al. (2018) Neurofilaments as Biomarkers in Neurological Disorders. Nature Reviews Neurology, 14, 577-589. https://doi.org/10.1038/s41582-018-0058-z
|
[11]
|
Bridel, C., van Wieringen, W.N., Zetterberg, H., et al. (2019) Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-Analysis. JAMA Neurology, 76, 1035-1048. https://doi.org/10.1001/jamaneurol.2019.1534
|
[12]
|
Oboudiyat, C., Glazer, H., Seifan, A., et al. (2013) Alzheimer’s Disease. Seminars in Neurology, 33, 313-329. https://doi.org/10.1055/s-0033-1359319
|
[13]
|
Mattsson, N., Andreasson, U., Zetterberg, H., et al. (2017) Alzheimer’s Disease Neuroimaging Initiative. Association of Plasma Neurofilament Light with Neurodegeneration in Patients with Alzheimer Disease. JAMA Neurology, 74, 557-566. https://doi.org/10.1001/jamaneurol.2016.6117
|
[14]
|
Hauser, S.L. and Cree, B.A.C. (2020) Treatment of Multiple Sclerosis: A Review. The American Journal of Medicine, 133, 1380-1390.e2. https://doi.org/10.1016/j.amjmed.2020.05.049
|
[15]
|
杨清燕, 陈涓涓, 吴军. 神经丝轻链在神经系统疾病中的研究进展[J]. 中西医结合心脑血管病杂志, 2021, 19(11): 1837-1840.
|
[16]
|
Barro, C., Benkert, P., Disanto, G., et al. (2018) Serum Neurofilament as a Predictor of Disease Worsening and Brain and Spinal Cord Atrophy in Multiple Sclerosis. Brain, 141, 2382-2391. https://doi.org/10.1093/brain/awy154
|
[17]
|
Thebault, S., Abdoli, M., Fereshtehnejad, S.M., et al. (2020) Serum Neurofilament Light Chain Predicts Long Term Clinical Outcomes in Multiple Sclerosis. Scientific Reports, 10, 10381. https://doi.org/10.1038/s41598-020-67504-6
|
[18]
|
Bäckström, D., Linder, J., Jakobson, M.O., S, et al. (2020) NfL as a Biomarker for Neurodegeneration and Survival in Parkinson Disease. Neurology, 95, e827-e838. https://doi.org/10.1212/WNL.0000000000010084
|
[19]
|
Olsson, B., Portelius, E., Cullen, N.C., et al. (2019) Association of Cerebrospinal Fluid Neurofilament Light Protein Levels with Cognition in Patients with Dementia, Motor Neuron Disease, and Movement Disorders. JAMA Neurology, 76, 318-325. https://doi.org/10.1001/jamaneurol.2018.3746
|